These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28671346)

  • 1. Prothrombotic aspects of sickle cell disease.
    Sparkenbaugh E; Pawlinski R
    J Thromb Haemost; 2017 Jul; 15(7):1307-1316. PubMed ID: 28671346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease.
    Chantrathammachart P; Mackman N; Sparkenbaugh E; Wang JG; Parise LV; Kirchhofer D; Key NS; Pawlinski R
    Blood; 2012 Jul; 120(3):636-46. PubMed ID: 22661702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombosis and sickle cell disease.
    De Franceschi L; Cappellini MD; Olivieri O
    Semin Thromb Hemost; 2011 Apr; 37(3):226-36. PubMed ID: 21455857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor and thrombin in sickle cell anemia.
    Chantrathammachart P; Pawlinski R
    Thromb Res; 2012 May; 129 Suppl 2(Suppl 2):S70-2. PubMed ID: 22398014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the coagulation system in the pathogenesis of sickle cell disease.
    Nasimuzzaman M; Malik P
    Blood Adv; 2019 Oct; 3(20):3170-3180. PubMed ID: 31648337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
    Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
    J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease.
    Sparkenbaugh EM; Chen C; Brzoska T; Nguyen J; Wang S; Vercellotti GM; Key NS; Sundd P; Belcher JD; Pawlinski R
    Blood; 2020 May; 135(20):1783-1787. PubMed ID: 31977004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interplay between coagulation and vascular inflammation in sickle cell disease.
    Sparkenbaugh E; Pawlinski R
    Br J Haematol; 2013 Jul; 162(1):3-14. PubMed ID: 23593937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential contribution of FXa and thrombin to vascular inflammation in a mouse model of sickle cell disease.
    Sparkenbaugh EM; Chantrathammachart P; Mickelson J; van Ryn J; Hebbel RP; Monroe DM; Mackman N; Key NS; Pawlinski R
    Blood; 2014 Mar; 123(11):1747-56. PubMed ID: 24449213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelets, coagulation, and fibrinolysis in sickle cell disease: their possible role in vascular occlusion.
    Francis RB
    Blood Coagul Fibrinolysis; 1991 Apr; 2(2):341-53. PubMed ID: 1893065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercoagulability in sickle cell disease: a curious paradox.
    Ataga KI; Orringer EP
    Am J Med; 2003 Dec; 115(9):721-8. PubMed ID: 14693325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercoagulable state in sickle cell disease.
    Faes C; Sparkenbaugh EM; Pawlinski R
    Clin Hemorheol Microcirc; 2018; 68(2-3):301-318. PubMed ID: 29614638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis for the prothrombotic state in sickle cell disease.
    Shet AS; Lizarralde-Iragorri MA; Naik RP
    Haematologica; 2020 Oct; 105(10):2368-2379. PubMed ID: 33054077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ineffective erythropoiesis in sickle cell disease: new insights and future implications.
    El Nemer W; Godard A; El Hoss S
    Curr Opin Hematol; 2021 May; 28(3):171-176. PubMed ID: 33631786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cells and thrombin generation in sickle cell disease.
    Whelihan MF; Lim MY; Key NS
    Thromb Res; 2014 May; 133 Suppl 1(0 1):S52-3. PubMed ID: 24759144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of coagulation activation with clinical complications in sickle cell disease.
    Ataga KI; Brittain JE; Desai P; May R; Jones S; Delaney J; Strayhorn D; Hinderliter A; Key NS
    PLoS One; 2012; 7(1):e29786. PubMed ID: 22253781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice.
    Arumugam PI; Mullins ES; Shanmukhappa SK; Monia BP; Loberg A; Shaw MA; Rizvi T; Wansapura J; Degen JL; Malik P
    Blood; 2015 Oct; 126(15):1844-55. PubMed ID: 26286849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sickle Cell Disease and Thromboembolism: New Insights on the Pathophysiology, Diagnosis, and Treatment.
    Dobie G
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke.
    Hyacinth HI; Adams RJ; Greenberg CS; Voeks JH; Hill A; Hibbert JM; Gee BE
    PLoS One; 2015; 10(8):e0134193. PubMed ID: 26305570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excess of heme induces tissue factor-dependent activation of coagulation in mice.
    Sparkenbaugh EM; Chantrathammachart P; Wang S; Jonas W; Kirchhofer D; Gailani D; Gruber A; Kasthuri R; Key NS; Mackman N; Pawlinski R
    Haematologica; 2015 Mar; 100(3):308-14. PubMed ID: 25596265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.